|
Referenz |
Lieferant |
Beschreibung |
Einheit |
Preis exkl. MwSt. |
|
|
|
USP-1478561 |
USP |
Omeprazole Related Compound I (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1-oxide) 15 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1478571 |
USP |
Ondansetron (9-Methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one) 300 mg |
|
672.00 CHF
705.60 €
|
|
|
|
USP-1478582 |
USP |
Ondansetron Hydrochloride (9-Methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride dihydrate) 300 mg |
|
630.67 CHF
662.20 €
|
|
|
|
USP-1478593 |
USP |
Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride) 50 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1478618 |
USP |
Ondansetron Related Compound C (9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one) 30 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1478629 |
USP |
Ondansetron Related Compound D - 1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one 30 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1478630 |
USP |
Ondansetron Resolution Mixture 50 mg |
|
1,653.33 CHF
1,736.00 €
|
|
|
|
USP-1478645 |
USP |
Ondansetron Related Compound G (3-[(1H-Imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one) 15 mg |
|
1,372.00 CHF
1,440.60 €
|
|
|
|
USP-1478651 |
USP |
Ononin 50 mg |
|
525.33 CHF
551.60 €
|
|
|
|
USP-1478673 |
USP |
Orbifloxacin 350 mg |
|
1,672.00 CHF
1,755.60 €
|
|
|
|
USP-1478800 |
USP |
Orlistat 200 mg |
|
1,022.67 CHF
1,073.80 €
|
|
|
|
USP-1478811 |
USP |
Orlistat Related Compound A - (3S,4S)3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone 25 mg |
|
1,529.33 CHF
1,605.80 €
|
|
|
|
USP-1478822 |
USP |
Orlistat Related Compound B - diisopropyl bicarbamate 20 mg |
|
1,572.00 CHF
1,650.60 €
|
|
|
|
USP-1478833 |
USP |
Orlistat Related Compound C (Triphenylphosphine Oxide) 25 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1478855 |
USP |
Orlistat Related Compound E (N-Formyl (S)-isoleucine (S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester) 10 mg |
|
1,648.00 CHF
1,730.40 €
|
|
|
|
USP-1478877 |
USP |
Orlistat Related Compound D Solution (2 x 1 mL (5 mg/mL)) ((3S,4R,6S)-3-Hexyl-2-oxo-6-undecyltetrahydro-2H-pyran-4-yl formyl-L-leucinate in acetonitrile) 2 x 1 mL |
|
1,633.33 CHF
1,715.00 €
|
|
|
|
USP-1479009 |
USP |
Orphenadrine Citrate 200 mg |
|
460.00 CHF
483.00 €
|
|
|
|
USP-1479010 |
USP |
Orphenadrine Related Compound A - (RS)-N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine citrate 50 mg |
|
865.33 CHF
908.60 €
|
|
|
|
USP-1479020 |
USP |
Orphenadrine Related Compound B (N-Ethyl-N,N-dimethyl[2-[2-methylbenzhydryloxy)ethyl]ammonium chloride, also known as N-Ethyl-N,N-dimethyl-2-[phenyl(2-tolyl)methoxy]ethanaminium chloride) 20 mg |
|
1,648.00 CHF
1,730.40 €
|
|
|
|
USP-1479031 |
USP |
Orphenadrine Related Compound C (N-methyl-2-[phenyl(o-tolyl)methoxy]ethanamine hydrochloride) 20 mg |
|
1,585.33 CHF
1,664.60 €
|
|
|
|
USP-1479053 |
USP |
Orphenadrine Related Compound E - (N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine) 50 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1479064 |
USP |
Orphenadrine Related Compound F - (N,N-Dimethyl-2-[phenyl(p-tolyl)methoxy]ethanamine citrate) 50 mg |
|
1,648.00 CHF
1,730.40 €
|
|
|
|
USP-1479202 |
USP |
Gamma-Oryzanol 50 mg |
|
485.33 CHF
509.60 €
|
|
|
|
USP-1479304 |
USP |
Oseltamivir Phosphate 200 mg |
|
620.00 CHF
651.00 €
|
|
|
|
USP-1479315 |
USP |
Oseltamivir Related Compound A - (3S,4R,5S)-ethyl 4-acetamido-5-amino-2-azido-3-(penta-3-yloxy)cyclohexanecarboxylate 10 mg |
|
1,728.00 CHF
1,814.40 €
|
|
|
|
USP-1481000 |
USP |
Oxacillin Sodium 200 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1481044 |
USP |
Oxacillin Related Compound C - (5-Methyl-3-phenylisoxazole-4-carboxylic acid) 15 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1481204 |
USP |
Oxaliplatin 125 mg |
|
2,358.67 CHF
2,476.60 €
|
|
|
|
USP-1481215 |
USP |
Oxaliplatin Related Compound A - Oxalic acid dihydrate 100 mg |
|
509.33 CHF
534.80 €
|
|
|
|
USP-1481226 |
USP |
Oxaliplatin Related Compound B - [SP-4-2-(1R-trans-)]-(1,2-cyclohexanediamine-N,N')dinitratoplatinum (II) 15 mg |
|
1,604.00 CHF
1,684.20 €
|
|
|
|
USP-1481237 |
USP |
Oxaliplatin Related Compound C - [1R-trans-(1,2-cyclohexanediamine-N,N')]-trans-dihydroxido-[oxalato(2-)-O,O']platinum (IV) 20 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1481248 |
USP |
Oxaliplatin Related Compound D - cis[(1S,2S)-1,2-cyclohexanediamine-N,N'][oxalato(2-)-O,O']platinum 10 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1481260 |
USP |
Oxaliplatin Related Compound F - [SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N-N')diiodidoplatinum(II) 25 mg |
|
1,558.67 CHF
1,636.60 €
|
|
|
|
USP-1481306 |
USP |
Oxaliplatin System Suitability [SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N')dichloridoplatinum (II) 25 mg |
|
1,498.67 CHF
1,573.60 €
|
|
|
|
USP-1482003 |
USP |
Oxandrolone CIII (CONTROLLED IN USA) 50 mg |
|
816.00 CHF
856.80 €
|
|
|
|
USP-1482014 |
USP |
Oxandrolone Related Compound A CIII (17beta-hydroxy-17alpha-methyl-2-oxa-5alpha-androst-7-en-3-one) (CONTROLLED IN USA) 20 mg |
|
1,921.60 CHF
2,017.68 €
|
|
|
|
USP-1482025 |
USP |
Oxandrolone Related Compound B - 17 beta-hydroxy-17-alpha-methyl-4-oxa-5 alpha-androsta-3-one CIII (CONTROLLED IN USA) 20 mg |
|
1,828.80 CHF
1,920.24 €
|
|
|
|
USP-1482036 |
USP |
Oxandrolone Related Compound C - 17,17-dimethyl-18-nor-2-oxa-5alpha-androst-13-en-3-one CIII (CONTROLLED IN USA) 20 mg |
|
1,921.60 CHF
2,017.68 €
|
|
|
|
USP-1482207 |
USP |
Oxaprozin 200 mg |
|
434.67 CHF
456.40 €
|
|
|
|
USP-1483006 |
USP |
Oxazepam CIV (200 mg) (CONTROLLED IN GERMANY) 200 mg |
|
857.60 CHF
900.48 €
|
|
|
|
USP-1483017 |
USP |
Oxazepam Related Compound A (15 mg) (7-chloro-5-phenyl-4,5-dihydro-1H-benzodiazepine-2,3-dione) 15 mg |
|
1,441.33 CHF
1,513.40 €
|
|
|
|
USP-1483028 |
USP |
Oxazepam Related Compound B - (7-Chloro-2-oxo-5-phenyl-2,3-dihydro-1H-benzodiazepin-3-yl acetate) - (CONTROLLED IN GERMANY) 15 mg |
|
1,153.60 CHF
1,211.28 €
|
|
|
|
USP-1483039 |
USP |
Oxazepam Related Compound C (15 mg) (6-chloro-4-phenylquinazoline-2-carbaldehyde) 15 mg |
|
1,529.33 CHF
1,605.80 €
|
|
|
|
USP-1483152 |
USP |
Oxcarbazepine 100 mg |
|
1,054.67 CHF
1,107.40 €
|
|
|
|
USP-1483163 |
USP |
Oxcarbazepine Related Compound A - N-Formyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide 10 mg |
|
1,529.33 CHF
1,605.80 €
|
|
|
|
USP-1483174 |
USP |
Oxcarbazepine Related Compound B - N-Acetyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide 10 mg |
|
1,529.33 CHF
1,605.80 €
|
|
|
|
USP-1483185 |
USP |
Oxcarbazepine Related Compound C - Acridin-9(10H)-one 10 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1483196 |
USP |
Oxcarbazepine Related Compound D (10-(10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamido)-5H-dibenzo[b,f]azepine-5-carboxamide) 10 mg |
|
1,648.00 CHF
1,730.40 €
|
|
|
|
USP-1483200 |
USP |
Oxcarbazepine Related Compound E - 10(11H)-Oxo-5H-dibenz[b,f]azepine 10 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1483301 |
USP |
Oxfendazole 200 mg |
|
460.00 CHF
483.00 €
|
|
